Mabwell (Shanghai) Bioscience Co., Ltd. announced that, effective 18 June 2026, Executive Director Mr. Hua Jun has been appointed as an authorised representative of the company under Rule 3.05 of the Hong Kong Listing Rules.
Mr. Hu Huiguo has simultaneously ceased to serve in this role. Following the change, Mabwell’s two authorised representatives are Mr. Hua Jun and Ms. Leung Kwan Wai.
The board currently comprises five executive directors—Mr. Tang Chunshan, Dr. Liu Datao (Chairman), Dr. Wu Hai, Mr. Hua Jun and Dr. Gui Xun—alongside four independent non-executive directors: Mr. Qin Zhengyu, Mr. Zhou Rui, Ms. Li Fan and Ms. Wang Fang.
The announcement was issued in Shanghai, PRC, and signed by Chairman and Executive Director Dr. Liu Datao on 18 June 2026.
Comments